Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris M Bunce

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Muscle & Nerve|October 15, 2011
A quick, simple and unbiased method to quantify C2C12 myogenic differentiationPedro Veliça, Chris M Bunce
Journal of Muscle Research and Cell Motility|December 5, 2008
Prostaglandins in muscle regenerationPedro Veliça, Chris M Bunce
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2018
The 'known-knowns', and 'known-unknowns' of extracellular Nm23-H1/NDPK proteinsChris M Bunce, Farhat L Khanim
Molecular and Cellular Endocrinology|January 30, 2010
Prostaglandin D2 inhibits C2C12 myogenesisPedro Veliça, Farhat L Khanim, Chris M Bunce
Blood Cancer Journal|October 6, 2022
Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignanciesChris M Bunce, Farhat L Khanim, Mark T Drayson
Haematologica|July 17, 2010
Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistanceRachel E Hayden, Guy Pratt, Mark T Drayson, et al.
Leukemia & Lymphoma|August 5, 2011
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approachesRachel E Hayden, Guy Pratt, Claudia Roberts, et al.
Molecular Cancer|December 17, 2009
Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancersPedro Veliça, Nicholas J Davies, Pedro P Rocha, et al.
Cancer Research|June 3, 2009
AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effectsNicholas J Davies, Rachel E Hayden, Paul J Simpson, et al.
British Journal of Haematology|January 14, 2010
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)Jim A Murray, Farhat L Khanim, Rachel E Hayden, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Muscle & Nerve|October 15, 2011
A quick, simple and unbiased method to quantify C2C12 myogenic differentiationPedro Veliça, Chris M Bunce
Journal of Muscle Research and Cell Motility|December 5, 2008
Prostaglandins in muscle regenerationPedro Veliça, Chris M Bunce
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 18, 2018
The 'known-knowns', and 'known-unknowns' of extracellular Nm23-H1/NDPK proteinsChris M Bunce, Farhat L Khanim
Molecular and Cellular Endocrinology|January 30, 2010
Prostaglandin D2 inhibits C2C12 myogenesisPedro Veliça, Farhat L Khanim, Chris M Bunce
Blood Cancer Journal|October 6, 2022
Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignanciesChris M Bunce, Farhat L Khanim, Mark T Drayson
Haematologica|July 17, 2010
Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistanceRachel E Hayden, Guy Pratt, Mark T Drayson, et al.
Leukemia & Lymphoma|August 5, 2011
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approachesRachel E Hayden, Guy Pratt, Claudia Roberts, et al.
Molecular Cancer|December 17, 2009
Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancersPedro Veliça, Nicholas J Davies, Pedro P Rocha, et al.
Cancer Research|June 3, 2009
AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effectsNicholas J Davies, Rachel E Hayden, Paul J Simpson, et al.
British Journal of Haematology|January 14, 2010
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)Jim A Murray, Farhat L Khanim, Rachel E Hayden, et al.
Pageof 2